GlassScriptPhysician profile
Yasmine Khan
NPI 1972577518
$6,614.64
in general payments reported to CMS, 2019-2025
33 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,073 · 2020: $666 · 2021: $989 · 2022: $843 · 2023: $1,423 · 2024: $1,104 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,024 · Education: $20.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,023.55 |
| Education | $20.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,116.12 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $1,243.68 | 2019-2025 | Ozempic, Wegovy |
| Dexcom, INC. | $1,096.92 | 2019-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $621.87 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Xeris Pharmaceuticals, INC. | $218.29 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Insulet Corporation | $144.01 | 2019-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $119.89 | 2019-2023 | |
| Medtronic, INC. | $110.54 | 2021-2024 | Minimed 780g |
| Abbvie INC. | $105.97 | 2019-2023 | |
| Medtronic Minimed, INC. | $96.59 | 2019 | |
| Amphastar Pharmaceuticals, INC. | $81.80 | 2024-2025 | Baqsimi |
| Tandem Diabetes Care, INC. | $68.53 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.30 | 2019 | |
| Alexion Pharmaceuticals, INC. | $55.59 | 2021 | |
| Amgen INC. | $49.35 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $40.66 | 2019 | |
| Ibsa Pharma INC. | $34.21 | 2019 | |
| Merck Sharp & Dohme LLC | $33.07 | 2019-2020 | |
| Ascensia Diabetes Care US INC. | $30.22 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.05 | 2023 | |
| Endo Pharmaceuticals INC. | $28.21 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $27.18 | 2019 | |
| Beta Bionics, INC. | $25.68 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Antares Pharma, INC. | $24.32 | 2022 | |
| Sequel Med Tech, LLC | $22.59 | 2025 | Twiist |
| Cequr Corporation | $20.00 | 2023 | Cequr Simplicity |
| Gilead Sciences, INC. | $19.82 | 2019 | |
| Eisai INC. | $18.65 | 2021 | |
| Astellas Pharma US INC | $16.23 | 2023 | Myrbetriq |
| Companion Medical, INC. | $15.54 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $14.18 | 2019 | |
| Strongbridge US INC. | $11.44 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yasmine Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.